Skip to main content

Table 3 Clinical features and laboratory results of the 38 IM patients

From: Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients

Num

Clinical type

HA test

EBV-VCA IgM

RT-PCR (copies/ml)

FISH positivity (per 100 cells)

FISH fluorescent

particles

outcome

1

mild

-

1:10

3.65×103

61.5%

8.52/+

alive

2

mild

+

-

7.05×103

3.0%

0.62/-

alive

3

mild

+

1:20

6.26×105

66.0%

11.42/+

alive

4

mild

-

1:160

6.21×103

54.5%

13.06/+

alive

5

mild

+

1:320

4.75×105

56.5%

13.78/+

alive

6

mild

-

-

2.02×104

62.0%

29.91/+

alive

7

mild

+

-

4.35×104

42.5%

7.78/+

alive

8

mild

+

1:640

9.05×104

65.0%

10.75/+

alive

9

mild

-

1:160

7.32×105

57.5%

11.35/+

alive

10

mild

+

1:160

3.45×103

72.5%

14.52/+

alive

11

mild

+

1:80

5.09×105

63.0%

7.89/+

alive

12

mild

-

1:160

7.32×103

56.5%

9.24/+

alive

13

mild

+

-

3.26×103

70.5%

6.28/+

alive

14

mild

-

1:80

8.25×105

50.5%

10.79/+

alive

15

mild

+

-

6.32×103

63.0%

11.24/+

alive

16

mild

-

-

9.37×105

41.5%

13.52/+

alive

17

mild

+

1:160

8.02×105

67.5%

14.36/+

alive

18

mild

+

1:80

7.22×103

70.5%

9.01/+

alive

19

mild

+

-

6.91×104

52.0%

19.43/+

alive

20

mild

-

1:20

6.44×103

45.5%

11.21/+

alive

21

mild

+

1:80

4.28×105

35.5%

12.36/+

alive

22

mild

+

1:20

1.75×104

45.5%

13.42/+

alive

23

mild

-

-

3.92×105

72.5%

14.53/+

alive

24

mild

+

1:320

1.07×104

65.5%

14.76/+

alive

25

mild

-

1:20

<500

42.0%

13.23/+

alive

26

mild

+

1:20

<500

53.0%

9.17/+

alive

27

mild

+

1:80

3.05×103

67.0%

8.79/+

alive

28

mild

+

-

3.59×105

71.0%

6.42/+

alive

29

mild

-

1:40

<500

39.0%

5.75 /+

alive

30

mild

-

1:20

<500

25.0%

12.31/+

alive

31

mild

-

1:320

2.63×104

51.5%

14.53/+

alive

32

severe/EBV-HLH

+

1:160

3.75×103

97.5%

32.82/+

alive

33

severe/EBV-HLH

-

1:320

4.5×107

100%

36.66/+

deceased

34

severe/EBV-HLH

+

1:640

3.05×104

89.5%

39.08/+

deceased

35

severe/EBV-HLH

+

-

5.05×104

91.0%

51.03/+

alive

36

severe/CAEBV

+

1:40

8.92×106

83.5%

53.44/+

alive

37

severe/CAEBV

-

1:320

8.26×107

100%

55.34/+

deceased

38

severe/CAEBV

+

1:80

4.75×105

87.5%

48.28/+

alive